Sees Q4 adjusted EBITDA $35M-$38M. The company said, “Cellebrite’s (CLBT) fourth-quarter and full-year 2025 expectations do not incorporate any anticipated contribution associated with the pending acquisition of Corellium, Inc.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- CLBT Earnings this Week: How Will it Perform?
- Cellebrite announces appointment of Windham as General Counsel, CCO
- Cellebrite announces Terry Crews to headline Cellebrite C2C User Summit
- Cellebrite expands reach with Agentic AI, announces its Autumn 2025 release
- Cellebrite DI: Positioned for Growth with Strategic Market Expansion and AI Integration